These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7766740

  • 1. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
    Robinson M, Sahba B, Avner D, Jhala N, Greski-Rose PA, Jennings DE.
    Aliment Pharmacol Ther; 1995 Feb; 9(1):25-31. PubMed ID: 7766740
    [Abstract] [Full Text] [Related]

  • 2. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB, Van Oene JC.
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [Abstract] [Full Text] [Related]

  • 3. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group.
    Bardhan KD, Hawkey CJ, Long RG, Morgan AG, Wormsley KG, Moules IK, Brocklebank D.
    Aliment Pharmacol Ther; 1995 Apr; 9(2):145-51. PubMed ID: 7605854
    [Abstract] [Full Text] [Related]

  • 4. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 5. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
    Gough AL, Long RG, Cooper BT, Fosters CS, Garrett AD, Langworthy CH.
    Aliment Pharmacol Ther; 1996 Aug; 10(4):529-39. PubMed ID: 8853756
    [Abstract] [Full Text] [Related]

  • 6. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

  • 7. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
    Berstad A, Hatlebakk JG.
    Aliment Pharmacol Ther; 1993 Jun 26; 7 Suppl 1():34-6, discussion 61-6. PubMed ID: 8490077
    [Abstract] [Full Text] [Related]

  • 8. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS, Rowley JL.
    Aliment Pharmacol Ther; 1996 Oct 26; 10(5):757-63. PubMed ID: 8899084
    [Abstract] [Full Text] [Related]

  • 9. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
    Sontag SJ, Schnell TG, Chejfec G, Kurucar C, Karpf J, Levine G.
    Aliment Pharmacol Ther; 1997 Feb 26; 11(1):147-56. PubMed ID: 9042987
    [Abstract] [Full Text] [Related]

  • 10. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
    Michel P, Lemaire M, Colin R, Bommelaer G, Rambaud JC, Dupas JL, Bigard MA, Verwaerd JC.
    Aliment Pharmacol Ther; 1994 Feb 26; 8(1):119-22. PubMed ID: 8186337
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.
    Mulder CJ, Westerveld BD, Smit JM, Oudkerk Pool M, Otten MH, Tan TG, van Milligen de Wit AW, de Groot GH, Dutch omeprazole MUPS study group.
    Eur J Gastroenterol Hepatol; 2002 Jun 26; 14(6):649-56. PubMed ID: 12072599
    [Abstract] [Full Text] [Related]

  • 12. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.
    Drugs; 2002 Jun 26; 62(7):1091-118. PubMed ID: 11985491
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA.
    Expert Opin Pharmacother; 2001 Oct 26; 2(10):1663-70. PubMed ID: 11825309
    [Abstract] [Full Text] [Related]

  • 14. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug 26; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rapid healing of gastric ulcers with lansoprazole.
    Bardhan KD, Ahlberg J, Hislop WS, Lindholmer C, Long RG, Morgan AG, Sjostedt S, Smith PM, Stig R, Wormsley KG.
    Aliment Pharmacol Ther; 1994 Apr 26; 8(2):215-20. PubMed ID: 8038354
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ, Jarvis B.
    Drugs; 2001 Apr 26; 61(12):1801-33. PubMed ID: 11693467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.